Neurogene ’s Gene Replacement Program is the Eighth Biopharmaceutical...

The research and resource development efforts of the Rett Syndrome Research Trust (RSRT) have helped generate an eighth biopharmaceutical program that tackles the root cause of Rett syndrome....(PRWeb May 19, 2022)Read the full story at https://www.prweb.com/releases/2022/5/prweb18686581.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news